These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2676252)
21. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Mancia G J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related]
23. Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Lüscher TF; Wenzel RR; Moreau P; Takase H Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():509-23. PubMed ID: 8562468 [TBL] [Abstract][Full Text] [Related]
24. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension]. Hradec J Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065 [TBL] [Abstract][Full Text] [Related]
25. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Matchar DB; McCrory DC; Orlando LA; Patel MR; Patel UD; Patwardhan MB; Powers B; Samsa GP; Gray RN Ann Intern Med; 2008 Jan; 148(1):16-29. PubMed ID: 17984484 [TBL] [Abstract][Full Text] [Related]
26. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials? Sambhi MP; Gavras H; Robertson JI; Smith WM West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511 [TBL] [Abstract][Full Text] [Related]
27. [Do converting enzyme inhibitors differ from each other in the treatment of hypertension?]. Laurent S; Billaud E; Kreft-Jais C Rev Prat; 1992 Dec; 42(20):2533-7. PubMed ID: 1299936 [TBL] [Abstract][Full Text] [Related]
28. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension. Weber MA Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure. DiBianco R Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682 [TBL] [Abstract][Full Text] [Related]
30. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors. Sica DA J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845 [TBL] [Abstract][Full Text] [Related]
31. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Plosker GL; Sorkin EM Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326 [TBL] [Abstract][Full Text] [Related]
32. [ACE-I for patients with hypertension]. Hatta T Nihon Rinsho; 2006 Aug; 64 Suppl 6():318-21. PubMed ID: 16981561 [No Abstract] [Full Text] [Related]